Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer
AbstractThe expression of the secreted factor Wnt-11 is elevated in several types of cancer, including colorectal cancer, where it promotes cancer cell migration and invasion. Analysis of colorectal cancer gene expression databases associated WNT11 mRNA expression with increased likelihood of metastasis in a subset of patients. WNT11 expression was correlated with the expression of the Wnt receptors FZD6, RYK, and PTK7, and the combined expression of WNT11, FZD6 and RYK or PTK7 was associated with an increased risk of 5-year mortality rates. Immunohistochemical analysis of Wnt-11 in a cohort of 357 colorectal cancer patients found significantly higher Wnt-11 levels in tumors, compared with benign tissue. Elevated Wnt-11 levels occurred more frequently in rectal tumors than in colonic tumors and in tumors from women than men. In univariate analysis, increased Wnt-11 expression was also associated with tumor invasion and increased 5-year mortality. High Wnt-11 levels were not associated with high levels of nuclear β-catenin, suggesting Wnt-11 is not simply an indicator for activation of β-catenin-dependent signaling. Expression of Wnt-11 in colorectal cancer cell lines expressing low endogenous Wnt-11 inhibited β-catenin/Tcf activity and increased ATF2-dependent transcriptional activity. WNT11 gene silencing and antibody-mediated inhibition of Wnt-11 in colorectal cancer cell lines expressing high Wnt-11 reduced their capacity for invasion. Together, these observations suggest that Wnt-11 could be a potential target for the treatment of patients with invasive colorectal cancer. View Full-Text
- Supplementary File 1:
ZIP-Document (ZIP, 110105 KB)
Share & Cite This Article
Gorroño-Etxebarria, I.; Aguirre, U.; Sanchez, S.; González, N.; Escobar, A.; Zabalza, I.; Quintana, J.M.; Vivanco, M.D.; Waxman, J.; Kypta, R.M. Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer. Cancers 2019, 11, 908.
Gorroño-Etxebarria I, Aguirre U, Sanchez S, González N, Escobar A, Zabalza I, Quintana JM, Vivanco MD, Waxman J, Kypta RM. Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer. Cancers. 2019; 11(7):908.Chicago/Turabian Style
Gorroño-Etxebarria, Irantzu; Aguirre, Urko; Sanchez, Saray; González, Nerea; Escobar, Antonio; Zabalza, Ignacio; Quintana, José M.; Vivanco, Maria D.; Waxman, Jonathan; Kypta, Robert M. 2019. "Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer." Cancers 11, no. 7: 908.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.